Trump made more than 1,000 stock trades in June amid Iran war and tariff fights
Key Takeaways
- •President Trump's June disclosure listed more than 1,000 securities trades valued between $78.1 million and $263.1 million, including purchases of Berkshire Hathaway, Visa, Mastercard and Cintas.
- •Trump made more than 21,000 securities trades across 2025, valued between $600 million and $1.86 billion, a pace observers describe as without precedent for a sitting president.
- •The disclosed trading has overlapped with major policy events, including the 2025 tariff pause, the escalating tariff war with Canada, and the US pressure campaign against Iran.
- •The White House denies impropriety, saying Trump's assets sit in a trust managed by his son, and federal conflict-of-interest law does not apply to the presidency as it does to other executive branch officials.
- •Senators Elizabeth Warren and Robert Garcia have sent letters demanding Trump identify the money managers behind the trades and calling for scrutiny of potential insider trading.

President Trump made more than 1,000 securities trades in June, according to a financial disclosure published Saturday, including purchases of Berkshire Hathaway, Visa, Mastercard and Cintas. The transactions, reported in ranges rather than exact figures as required under federal disclosure rules, totaled between $78.1 million and $263.1 million for the month. The largest single transaction disclosed was a June 22 sale of between $5 million and $25 million in a Vanguard exchange-traded fund, a span that is itself a single preset bracket on the standard federal transaction form, which uses broad value bands rather than exact amounts. Those filings, required under the Ethics in Government Act as strengthened by the 2012 STOCK Act, generally must be submitted within 30 days of a filer learning of a trade and no later than 45 days after it occurs.
The June filing adds to a pattern established over Trump's time back in office. He made more than 21,000 securities trades across 2025 alone, valued between $600 million and $1.86 billion, according to Bloomberg, with disclosures periodically showing the same security bought and sold on the same day. At roughly 50 trades a day, the pace has repeatedly been described by financial and ethics observers as without precedent for a sitting president, a comparison echoed by longtime Wall Street figures reviewing the filings.
The trading has continued alongside, and in some cases just ahead of, major policy moves. Reporting has previously tied disclosed purchases to the day before Trump's 2025 tariff pause and to periods surrounding tariff and export-control decisions affecting companies in his portfolio, including defense contractors and technology firms. The pattern has persisted into the current period, with the trades disclosed this week overlapping with an active US tariff war with Canada, now in its latest escalation after failed talks and new 50% tariffs, and with Washington's expanding economic and military pressure campaign against Iran, including this week's sanctions announcement from Treasury Secretary Scott Bessent.
The scale of trading activity has renewed market concerns about the overlap between presidential statements that move prices, such as tariff pause announcements or social media posts naming individual companies, and personal stock positions disclosed only after a delay under existing reporting rules. Traders have previously pointed to apparent timing overlaps between tariff and trade policy announcements and disclosed purchases in directly affected sectors, including technology, defense and steel. That has kept scrutiny elevated around any market-moving statement from the administration.
Because the trading account sits in a revocable trust with a family member as trustee rather than a blind trust, markets have no independent way to verify separation between policy decisions and portfolio positioning. That structure is likely to keep ethics-driven headline risk attached to Trump's public remarks on tariffs, Canada and Iran, regardless of the underlying economic substance of those remarks.
The White House has consistently rejected any suggestion of impropriety. A spokesperson has said Trump's assets are held in a trust managed by his son, adding that the president acts only in the public interest. Federal conflict of interest law does not apply to the presidency in the same way it does to other executive branch officials, a reading rooted in decades-old Justice Department Office of Legal Counsel opinions that were reaffirmed in 2009, meaning the arrangement, a revocable trust with a family member as sole trustee rather than a blind trust, faces no legal barrier despite falling short of the standard used by several recent predecessors. Presidents from Jimmy Carter through George W. Bush placed their holdings in blind trusts, while Barack Obama largely held Treasury securities and index funds.
Democratic lawmakers have pushed back on that framing. Senators Elizabeth Warren and Robert Garcia have sent letters demanding Trump identify the money managers behind the trades and explain specific transactions that preceded favorable policy announcements. They have also called for scrutiny of potential insider trading, citing the volume and timing of the transactions relative to policy moves. Ethics specialists including former White House counsel Richard Painter have argued that a president able to influence the value of stocks he personally owns represents a financial conflict of interest regardless of legality. Government watchdog groups have gone further, characterizing the volume of undisclosed and delayed trades as evidence of self-enrichment rather than routine portfolio management. The letters also feed into a broader, largely stalled Washington debate over stock trading by public officials, where bipartisan proposals to bar members of Congress and their spouses from trading individual stocks have repeatedly failed to advance, including the ETHICS Act, which a Senate committee approved in 2024 before it stalled without a floor vote.
With disclosures continuing to arrive in wide value ranges and often well after the statutory reporting window, the question of whether trading decisions are genuinely separated from policy decisions made in the same weeks remains unresolved as both the Canada tariff dispute and the Iran campaign continue to develop. The open questions ahead are concrete: whether the administration answers the Warren and Garcia letters, whether coming filings land inside or outside the 30-to-45-day reporting window, and whether Congress, where official stock-trading bans have stalled before, revisits the issue.